Infectious tolerance

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anna Škvorová (talk | contribs) at 20:45, 5 September 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Infectious tolerance is a term referring to a phenomenon where a tolerance-inducing state is transferred from one cell population to another. It can be induced in many ways; although it is often artificially induced, it is a natural in vivo process.[1] A number of research deal with the development of a strategy utilizing this phenomenon in transplantation immunology. The goal is to achieve long-term tolerance of the transplant through short-term therapy.[2]

History

The term "infectious tolerance" was originally used by Gershon and Kondo in 1970 [3] for suppression of naive lymphocyte populations by cells with regulatory function and for the ability to transfer a state of unresponsiveness from one animal to another.[4] Gershon and Kondo discovered that T cells can not only amplify but also diminish immune responses.[5] The T cell population causing this down-regulation was called suppressor T cells and was intensively studied for the following years (nowadays they are called regulatory T cells and are again a very attractive for research).[6] This and other research in the 1970s showed greater complexity of immune regulation, unfortunately these experiments were largely disregarded, as methodological difficulties prevented clear evidence. Later developed new tolerogenic strategies have provided strong evidence to re-evaluate the phenomenon of T cell mediated suppression, in particular the use of non-depleting anti-CD4 monoclonal antibodies, demonstrating that neither thymus nor clonal deletion is necessary to induce tolerance.[7] In 1989 was successfully induced classical transplantation tolerance to skin grafts in adult mice using antibodies blocking T cell coreceptors in CD4+ populations.[8] Later was shown that the effect of monoclonal antibodies is formation of regulatory T lymphocytes.[9] It has been shown that transfer of tolerance to other recipients can be made without further manipulation and that this tolerance transfer depends only on CD4+ T-lymphocytes.[10] Because second-generation tolerance arises in the absence of any monoclonal antibodies to CD4 or CD8, it probably represents a natural response of the immune system, which, once initiated, becomes self-sustaining. This ensures the long duration of once induced tolerance, for as long as the donor antigens are present.[11]

Dominant and linked suppression

References

  1. ^ Cobbold, S.; Waldmann, H. (October 1998). "Infectious tolerance". Current Opinion in Immunology. 10 (5): 518–524. ISSN 0952-7915. PMID 9794831.
  2. ^ Kendal, Adrian R.; Waldmann, Herman (October 2010). "Infectious tolerance: therapeutic potential". Current Opinion in Immunology. 22 (5): 560–565. doi:10.1016/j.coi.2010.08.002. ISSN 1879-0372. PMID 20829013.
  3. ^ Gershon, R. K.; Kondo, K. (December 1971). "Infectious immunological tolerance". Immunology. 21 (6): 903–914. ISSN 0019-2805. PMC 1408252. PMID 4943147.{{cite journal}}: CS1 maint: PMC format (link)
  4. ^ Gershon, R. K. (1975). "A disquisition on suppressor T cells". Transplantation Reviews. 26: 170–185. ISSN 0082-5948. PMID 1101469.
  5. ^ Gershon, R. K.; Kondo, K. (May 1970). "Cell interactions in the induction of tolerance: the role of thymic lymphocytes". Immunology. 18 (5): 723–737. ISSN 0019-2805. PMC 1455602. PMID 4911896.
  6. ^ Sakaguchi, Shimon; Wing, Kajsa; Miyara, Makoto (November 2007). "Regulatory T cells - a brief history and perspective". European Journal of Immunology. 37 Suppl 1: S116–123. doi:10.1002/eji.200737593. ISSN 0014-2980. PMID 17972355.
  7. ^ Qin, S. X.; Wise, M.; Cobbold, S. P.; Leong, L.; Kong, Y. C.; Parnes, J. R.; Waldmann, H. (December 1990). "Induction of tolerance in peripheral T cells with monoclonal antibodies". European Journal of Immunology. 20 (12): 2737–2745. doi:10.1002/eji.1830201231. ISSN 0014-2980. PMID 1702726.
  8. ^ Qin, S. X.; Cobbold, S.; Benjamin, R.; Waldmann, H. (1989-03-01). "Induction of classical transplantation tolerance in the adult". The Journal of Experimental Medicine. 169 (3): 779–794. ISSN 0022-1007. PMC 2189271. PMID 2647894.
  9. ^ Tilney, N. L.; Guttmann, R. D. (1997-10-15). "Effects of initial ischemia/reperfusion injury on the transplanted kidney". Transplantation. 64 (7): 945–947. ISSN 0041-1337. PMID 9381538.
  10. ^ Kahan, B. D. (December 1993). "Toward a rational design of clinical trials of immunosuppressive agents in transplantation". Immunological Reviews. 136: 29–49. ISSN 0105-2896. PMID 8132202.
  11. ^ Qin, S.; Cobbold, S. P.; Pope, H.; Elliott, J.; Kioussis, D.; Davies, J.; Waldmann, H. (1993-02-12). ""Infectious" transplantation tolerance". Science. 259 (5097): 974–977. doi:10.1126/science.8094901. ISSN 0036-8075. PMID 8094901.